Silexion Therapeutics Files 8-K with Financials
Ticker: SLXNW · Form: 8-K · Filed: Apr 23, 2025 · CIK: 2022416
Sentiment: neutral
Topics: financial-statements, exhibits, warrants
Related Tickers: SLXN
TL;DR
Silexion Therapeutics filed an 8-K on 4/23/25, showing financials and warrants at $1.15.
AI Summary
Silexion Therapeutics Corp. (formerly Biomotion Sciences) filed an 8-K on April 23, 2025, reporting on financial statements and exhibits. The company, incorporated in the Cayman Islands and headquartered in Ramat-Gan, Israel, is involved in biological products. The filing also notes the existence of warrants exercisable for ordinary shares at $1.150 per share.
Why It Matters
This filing provides updated financial information and details on outstanding warrants for Silexion Therapeutics, which is crucial for investors to assess the company's financial health and potential dilution.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial statements and exhibits, not indicating any immediate operational or financial distress.
Key Numbers
- $1.150 — Warrant Exercise Price (Price at which warrants can be exercised for ordinary shares.)
Key Players & Entities
- Silexion Therapeutics Corp (company) — Registrant
- Biomotion Sciences (company) — Former company name
- April 23, 2025 (date) — Date of report
- Cayman Islands (jurisdiction) — State of incorporation
- Ramat-Gan, Israel (location) — Principal executive offices
- $1.150 (dollar_amount) — Exercise price for warrants
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on financial statements and exhibits, as indicated by the 'ITEM INFORMATION: Financial Statements and Exhibits' section.
When was Silexion Therapeutics Corp. formerly known as?
Silexion Therapeutics Corp. was formerly known as Biomotion Sciences, as stated in the filing under 'FORMER COMPANY'.
What is the exercise price for the warrants mentioned in the filing?
The filing mentions warrants exercisable for ordinary shares at an exercise price of $1.150 per share.
Where are Silexion Therapeutics Corp.'s principal executive offices located?
Silexion Therapeutics Corp.'s principal executive offices are located at 12 Abba Hillel Road, Ramat-Gan, Israel.
In which jurisdiction was Silexion Therapeutics Corp. incorporated?
Silexion Therapeutics Corp. was incorporated in the Cayman Islands.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 23, 2025 regarding Silexion Therapeutics Corp (SLXNW).